Press releaseBusiness Wire
Iambic Therapeutics
IAM · NASDAQ
$15.42−$0.92 (−5.63%)TodayMarket open · · Delayed 15 min
Prev close $16.34
IAM key statistics
- Market cap
- —
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 2.49M
- Volume
- 673.22K
- Open price
- $16.31
- High today
- $17.50
- Low today
- $15.00
- 52 Week high
- $25.00
- 52 Week low
- $16.15
Iambic Therapeutics (IAM) at a glance
Iambic Therapeutics (IAM) last traded at $15.42.
Today the stock has traded between $15.00 and $17.50. The current price is 2.8% above the day's low and 11.9% below its high.
Volume so far is 673.22K shares, below the average of 2.49M shares a day.
Over the past year Iambic Therapeutics has ranged from $16.15 to $25.00, and now sits -8% of the way up that range.
IAM news
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0005+150.00%
- NWGLCL Workshop Group$0.1331+11.85%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007−7.14%
- FITYFifty 1 Labs$0.0001−66.67%
- CBDW1606$0.0003+50.00%
- PRSOPeraso$0.5668+47.72%
- FRTTFort Technology$0.6963+29.69%
- CBDLCBD Life Sciences$0.0002+0.00%
- WFFWF Holding$0.0913−5.49%
- NBNDNetBrands$0.001−14.16%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.54+1.35%
- CTYCITY THERAPEUTICS$20.52−4.38%
- AMROAmaero$5.75+2.50%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.27−0.19%
- TRXBTRex Bio$14.70−0.68%
- RTSNRetension Pharmaceuticals$16.56+1.41%
- PAXGUPine Tree Acquisition$9.99+0.10%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.28−1.68%
- RZAIROZE AI$10.22+0.69%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.